ALEXANDRA LAPPLE: Open Payments
NPI 1023603693 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 34 payments from 11 companies in 2025. Trend: 2023 $802 · 2024 $745 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 10 | $229 |
| Collegium Pharmaceutical, Inc. | 11 | $226 |
| Averitas Pharma Inc. | 3 | $59 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Medtronic, Inc. | 2 | $33 |
| MML US, Inc. | 1 | $30 |
| Novocure Inc. | 1 | $23 |
| Azurity Pharmaceuticals, Inc. | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| Amgen Inc. | 1 | $21 |
Products named: XTAMPZA, General - Pain Management, WaveWriter Alpha Prime 16, QUTENZA, Belbuca, RELISTOR, INCEPTIV, ReActiv8.
Industry payments across VA — which companies pay providers there.
